MX9206150A - Agentes antiinflamatorios de derivados de tripeptidos - Google Patents
Agentes antiinflamatorios de derivados de tripeptidosInfo
- Publication number
- MX9206150A MX9206150A MX9206150A MX9206150A MX9206150A MX 9206150 A MX9206150 A MX 9206150A MX 9206150 A MX9206150 A MX 9206150A MX 9206150 A MX9206150 A MX 9206150A MX 9206150 A MX9206150 A MX 9206150A
- Authority
- MX
- Mexico
- Prior art keywords
- inflammatory agents
- tripeptide derivatives
- saturated
- carbon atoms
- unsaturated
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78060791A | 1991-10-23 | 1991-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9206150A true MX9206150A (es) | 1993-08-01 |
Family
ID=25120082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9206150A MX9206150A (es) | 1991-10-23 | 1992-10-23 | Agentes antiinflamatorios de derivados de tripeptidos |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU2882792A (en, 2012) |
MX (1) | MX9206150A (en, 2012) |
PT (1) | PT101001A (en, 2012) |
TW (1) | TW240234B (en, 2012) |
WO (1) | WO1993008211A1 (en, 2012) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5440015A (en) * | 1992-07-21 | 1995-08-08 | Glycomed Incorporated | Selectin peptide medicaments for treating disease |
US5883077A (en) * | 1992-12-15 | 1999-03-16 | Corvas International, Inc. | Inhibitors of factor Xa |
US5885967A (en) * | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5488037A (en) * | 1994-03-04 | 1996-01-30 | Eli Lilly And Company | Antithrombotic agents |
ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
US5436229A (en) * | 1994-03-04 | 1995-07-25 | Eli Lilly And Company | Bisulfite adducts of arginine aldehydes |
US5602101A (en) * | 1994-03-04 | 1997-02-11 | Eli Lilly And Company | Antithrombotic agents |
US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
US5439888A (en) * | 1994-03-04 | 1995-08-08 | Eli Lilly And Company | Antithrombotic agents |
US5484772A (en) * | 1994-03-04 | 1996-01-16 | Eli Lilly And Company | Antithrombotic agents |
CA2143533A1 (en) * | 1994-03-04 | 1995-09-05 | Kenneth D. Kurz | Antithrombotic agents |
US5914319A (en) * | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US6664349B2 (en) | 2001-03-29 | 2003-12-16 | Equistar Chemicals, Lp | Ethylene polymerization process |
GB0205527D0 (en) * | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5754157A (en) * | 1980-09-19 | 1982-03-31 | Nippon Kayaku Co Ltd | L-argininal derivative and its preparation |
AU600226B2 (en) * | 1985-02-04 | 1990-08-09 | Merrell Pharmaceuticals Inc. | Novel peptidase inhibitors |
JPH075634B2 (ja) * | 1987-10-30 | 1995-01-25 | 日東紡績株式会社 | トリペプチド類及びこれを含有する抗プラスミン剤 |
-
1992
- 1992-10-19 AU AU28827/92A patent/AU2882792A/en not_active Abandoned
- 1992-10-19 WO PCT/US1992/008901 patent/WO1993008211A1/en active Application Filing
- 1992-10-23 PT PT10100192A patent/PT101001A/pt not_active Application Discontinuation
- 1992-10-23 MX MX9206150A patent/MX9206150A/es unknown
- 1992-11-11 TW TW81109045A patent/TW240234B/zh active
Also Published As
Publication number | Publication date |
---|---|
WO1993008211A1 (en) | 1993-04-29 |
TW240234B (en, 2012) | 1995-02-11 |
PT101001A (pt) | 1994-01-31 |
AU2882792A (en) | 1993-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9206150A (es) | Agentes antiinflamatorios de derivados de tripeptidos | |
LU90987I2 (fr) | Copaxone et ses dérivés pharmaceutiquement acceptables | |
ES2114931T3 (es) | Nuevos esteres esteroidales. | |
FI952680A0 (fi) | Injektoitavia taksaanijohdannaisiin pohjautuvia koostumuksia | |
BRPI0111639B8 (pt) | uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica. | |
LU91223I2 (fr) | Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan) | |
KR950010890A (ko) | 폐경기 증후군의 치료방법 | |
ES2104090T3 (es) | Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2098004T3 (es) | Peptidos derivados de trifluoro-metil-cetonas con una actividad inhibidora de la elastasa leucocitaria humana (hle), su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2054012T3 (es) | Composiciones biocidas. | |
AR005999A1 (es) | Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos | |
ES2155566T3 (es) | Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia. | |
KR950010889A (ko) | 혈관형성 및 혈관형성성 질병을 억제하는 방법 | |
DE69412049D1 (de) | Hemmung von dysfunctionalen Uterusblutungen | |
KR970025615A (ko) | 암 전이 억제제 | |
ES2062443T3 (es) | Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ITRM910002A1 (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. | |
ES2056153T3 (es) | Expectorante que comprende un derivado hidroxialquilcisteina. | |
ES2171444T3 (es) | Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales. | |
IT1251838B (it) | Uso della nimesulide nel trattamento della cataratta | |
ATE182071T1 (de) | Fluorkohlenstoff-emulsionen mit reduzierten gaseinschliessenden eigenschaften in den lungen | |
FI953566A0 (fi) | Tahdospironia tai sen analogeja sisältäviä koostumuksia | |
AR040279A2 (es) | Composiciones que contiene sal de sertralina | |
ECSP941031A (es) | Derivados de timosina alfa 1 | |
ES2086195T3 (es) | Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |